ASPIASP Isotopes Inc.
Is the business good?
Margins steady. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margins have held roughly steady, a stable cost structure.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is ASPI?
ASP Isotopes Inc. spent more than it took in: an operating loss of $99M on $31M of revenue, 12 months to Q2 2026.
Operating loss · on $31M of revenue · 12 months to Q2 2026
- Share count, year on year
- +68%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 71%
R&D as % of revenue
- Gross margin
- 18%
Gross margin
| Year | Operating margin |
|---|---|
| FY2022 | −150770% |
| FY2023 | −3705% |
| FY2024 | −636% |
| FY2025 | −251% |
Details›
- Gross margin12 months to Q2 2026
- 18%
- Operating margin12 months to Q2 2026
- −321%
- Net margin12 months to Q2 2026
- −380%
- Free cash flow margin
- −271%
- R&D as % of revenue
- 71%
- Revenue, trailing twelve months
- $31M
- Free cash flow, trailing twelve months
- −$84M
- Net income, trailing twelve months
- −$117M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from ASPI and who it buys from, as the companies report it.
- One customer32%
Share of revenue · FY2025 10-K
- Customer one14%
Share of revenue · FY2025 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; ASPI’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.